197 related articles for article (PubMed ID: 10600000)
1. Expression of the costimulator molecules, CD80, CD86, CD28, and CD152 on lymphocytes from neonates and young children.
Elliott SR; Macardle PJ; Roberton DM; Zola H
Hum Immunol; 1999 Nov; 60(11):1039-48. PubMed ID: 10600000
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory molecules in human periodontal disease tissues.
Gemmell E; McHugh GB; Grieco DA; Seymour GJ
J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
[TBL] [Abstract][Full Text] [Related]
4. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
5. Lower percentage of CD8(high+)CD152(+) but not CD8(high+)CD28(+) T lymphocytes in the elderly may be reverted by interleukin 2 in vitro.
Trzonkowski P; Myśliwska J; Szmit E; Zak M; Foerster J; Myśliwski A
Mech Ageing Dev; 2002 May; 123(9):1283-93. PubMed ID: 12020949
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human inducible costimulator ligand expression and function.
Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
[TBL] [Abstract][Full Text] [Related]
7. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis.
Mena E; Rohowsky-Kochan C
Acta Neurol Scand; 1999 Aug; 100(2):92-6. PubMed ID: 10442449
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis.
Hattori H; Okano M; Yoshino T; Akagi T; Nakayama E; Saito C; Satoskar AR; Ogawa T; Azuma M; Nishizaki K
Clin Exp Allergy; 2001 Aug; 31(8):1242-9. PubMed ID: 11529894
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
[TBL] [Abstract][Full Text] [Related]
11. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
12. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
14. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory molecule.
Pistillo MP; Tazzari PL; Ellis JH; Ferrara GB
Tissue Antigens; 2000 Mar; 55(3):229-38. PubMed ID: 10777098
[TBL] [Abstract][Full Text] [Related]
17. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Steiner K; Moosig F; Csernok E; Selleng K; Gross WL; Fleischer B; Bröker BM
Clin Exp Immunol; 2001 Oct; 126(1):143-50. PubMed ID: 11678911
[TBL] [Abstract][Full Text] [Related]
19. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
20. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]